Standard treatment according to the Clinical protocols

OTHER12 trials

Sponsors

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

Conditions

Age-Related Macular DegenerationAlopeciaBladder CancerCOVIDCoronavirusCovid-19Diabetes MellitusPneumonia

Phase 1

Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells

CompletedNCT04184258

Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusSystemic Lupus Erythematosus

Start: 2019-07-01End: 2020-12-31Updated: 2021-01-22

Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells

CompletedNCT04382547

Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusCoronavirus, COVID, Covid-19 +4

Start: 2020-05-11End: 2021-06-30Updated: 2021-08-23

Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells

CompletedNCT04426643

Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusUrinary Incontinence

Start: 2020-08-01End: 2021-03-31Updated: 2021-05-25

Treatment of Stress Urinary Incontinence in Women With Autologous Adipose-derived Mesenchymal Stem Cells

CompletedNCT04446884

Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusStress Urinary Incontinence

Start: 2018-03-01End: 2019-12-31Updated: 2020-06-25

Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells

Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusBladder Cancer, Renal Cancer

Start: 2022-03-01End: 2023-12-31Target: 20Updated: 2022-01-14

Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells

Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusAge-Related Macular Degeneration

Start: 2022-03-01End: 2023-12-31Target: 20Updated: 2022-09-14

Treatment of Postoperative Hypoparathyroidism Using Cultured Allogenic Parathyroid Cells

Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusPostoperative Hypoparathyroidism

Start: 2022-03-01End: 2023-12-31Target: 20Updated: 2022-01-13

The Treatment of Patients With Type 1 Diabetes Mellitus With Autologous Tolerogenic Dendritic Cells

CompletedNCT05207995

Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusDiabetes Mellitus

Start: 2022-03-01End: 2023-12-26Updated: 2025-12-02

Treatment of Alopecia Using Follicular Stem Cells

Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusAlopecia

Start: 2022-03-01End: 2023-12-31Target: 30Updated: 2022-01-27

Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells

Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusSystemic Sclerosis

Start: 2022-09-01End: 2023-12-31Target: 30Updated: 2022-09-14

Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells

Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusRecurrent Pregnancy Loss

Start: 2022-11-01End: 2023-12-31Target: 20Updated: 2022-08-29

Phase 2

Treatment of Recurrent Bladder Cancer With Dendritic Cells

CompletedNCT04184232

Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusBladder Cancer

Start: 2019-07-01End: 2020-12-31Updated: 2021-01-22